ResearcherChampalimaud FoundationActive in the last 2 years

Carlos Bilreiro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7755-0842; OpenAlex author ID A5000206918. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2024: 2 papers

Papers 2

Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-023-10381-0 ↗
Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management. Co-author DOI 10.1016/j.ejro.2024.100553 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Celso Matos · 2 shared papers, 2024 · strength 0.59
- Paper Diffusion-weighted imaging for determining response to neoadjuvant therapy in pancreatic cancer: a systematic review an… DOI 10.1007/s00330-023-10381-0 ↗
- Paper Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management. DOI 10.1016/j.ejro.2024.100553 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.